NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS Avicanna Inc. a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, announces the filing of the Company’s unaudited interim …
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/
Avicanna Inc. (” Avicanna ” or the ” Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, announces the filing of the Company’s unaudited interim financial statements for the three month period ended March 31, 2021, and accompanying management’s discussion and analysis, and related certifications (collectively, the “ Documents ”). Electronic copies of the Documents are available on SEDAR ( www.sedar.com ) under the Company’s issuer profile.
The Company is in the process of preparing its unaudited interim financial statements, management’s discussion and analysis, and related certifications (collectively, the “ Q2 Filings ”) for the three and six month period ended June, 30, 2021, and anticipates filing the Q2 Filings on or prior to...
Read Full Story: https://investingnews.com/news/cannabis-investing/avicanna-announces-filing-of-interim-financial-statements-for-three-month-period-ended-march-31-2021/
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.